ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 9 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E0D705 | Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D70M | Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D728 | Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D729 | Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D73Z | Introduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D74Z | Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D76Z | Introduction of Nutritional Substance into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D77Z | Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7BZ | Introduction of Anesthetic Agent into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7GC | Introduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7HZ | Introduction of Radioactive Substance into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7KZ | Introduction of Other Diagnostic Substance into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7RZ | Introduction of Antiarrhythmic into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0D7TZ | Introduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |
| 3E0DX04 | Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, External Approach | Valid |
| 3E0DX05 | Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach | Valid |
| 3E0DX0M | Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach | Valid |
| 3E0DX28 | Introduction of Oxazolidinones into Mouth and Pharynx, External Approach | Valid |
| 3E0DX29 | Introduction of Other Anti-infective into Mouth and Pharynx, External Approach | Valid |
| 3E0DX3Z | Introduction of Anti-inflammatory into Mouth and Pharynx, External Approach | Valid |
| 3E0DX4Z | Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, External Approach | Valid |
| 3E0DX6Z | Introduction of Nutritional Substance into Mouth and Pharynx, External Approach | Valid |
| 3E0DX7Z | Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, External Approach | Valid |
| 3E0DXBZ | Introduction of Anesthetic Agent into Mouth and Pharynx, External Approach | Valid |
| 3E0DXGC | Introduction of Other Therapeutic Substance into Mouth and Pharynx, External Approach | Valid |
| 3E0DXHZ | Introduction of Radioactive Substance into Mouth and Pharynx, External Approach | Valid |
| 3E0DXKZ | Introduction of Other Diagnostic Substance into Mouth and Pharynx, External Approach | Valid |
| 3E0DXNZ | Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, External Approach | Valid |
| 3E0DXRZ | Introduction of Antiarrhythmic into Mouth and Pharynx, External Approach | Valid |
| 3E0DXTZ | Introduction of Destructive Agent into Mouth and Pharynx, External Approach | Valid |
| 3E0E304 | Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach | Valid |
| 3E0E305 | Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach | Valid |
| 3E0E30M | Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach | Valid |
| 3E0E328 | Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach | Valid |
| 3E0E329 | Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach | Valid |
| 3E0E33Z | Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach | Valid |
| 3E0E36Z | Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach | Valid |
| 3E0E37Z | Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3BZ | Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3GC | Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3HZ | Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3KZ | Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3SF | Introduction of Other Gas into Products of Conception, Percutaneous Approach | Valid |
| 3E0E3TZ | Introduction of Destructive Agent into Products of Conception, Percutaneous Approach | Valid |
| 3E0E4GC | Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach | Valid |
| 3E0E704 | Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E705 | Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E70M | Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E728 | Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E729 | Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E73Z | Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E76Z | Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E77Z | Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7BZ | Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7GC | Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7HZ | Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7KZ | Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7SF | Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E7TZ | Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening | Valid |
| 3E0E804 | Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E805 | Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E80M | Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E828 | Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E829 | Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E83Z | Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E86Z | Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E87Z | Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8BZ | Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8GC | Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8HZ | Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8KZ | Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8SF | Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0E8TZ | Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F304 | Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F305 | Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F30M | Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F328 | Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F329 | Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F33Z | Introduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F36Z | Introduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F37Z | Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3BZ | Introduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3HZ | Introduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3KZ | Introduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3SF | Introduction of Other Gas into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F3TZ | Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach | Valid |
| 3E0F4GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Endoscopic Approach | Valid |
| 3E0F704 | Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F705 | Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F70M | Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F728 | Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F729 | Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F73Z | Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening | Valid |